| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |